Neutralizing Power of Anti-SARS-CoV-2 (Anti-COVID-19) Serum Antibodies (PNAS)
Study of the Neutralizing Power of Anti-SARS-CoV-2 (Anti-COVID-19) Serum Antibodies
Sponsor: Centre Hospitalier Régional d'Orléans
Terminated
Now that the COVID period has passed, patient recruitment has fallen off.
Other terminated trials from Centre Hospitalier Régional d'Orléans
- Stroke, Acute · Phase NA · Aug 2024
- Hypovolemia · Phase NA · May 2024
- Parkinson Disease · Phase NA · Dec 2022
- Muscle Weakness · Phase NA · Dec 2021
- Spouse Abuse · Jul 2021
See all terminations from Centre Hospitalier Régional d'Orléans
This NA trial investigates COVID-19 and SARS CoV 2 Infection and is currently terminated or withdrawn. Centre Hospitalier Régional d'Orléans leads this study, which shows 8 recorded versions since 2022 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.
Status Flow
Change History
8 versions recorded-
Dec 2024 — Present [monthly]
Terminated NA
Status: Recruiting → Terminated
-
Sep 2024 — Dec 2024 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Feb 2024 — Jul 2024 [monthly]
Recruiting NA
-
Feb 2023 — Feb 2024 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
▶ Show 3 earlier versions
-
Sep 2022 — Feb 2023 [monthly]
Not Yet Recruiting NA
-
Jun 2022 — Sep 2022 [monthly]
Not Yet Recruiting NA
-
May 2022 — Jun 2022 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Centre Hospitalier Régional d'Orléans
For direct contact, visit the study record on ClinicalTrials.gov .